CPN1 and Alzheimer disease: As revealed in the literature, antibiotics against CPn were noted to decrease the deposition of amyloids, oxidative stress, and inflammation in AD models (Yulug et al., 2018; Balducci and Forloni, 2019); these antibiotics possess the capacity to traverse the blood–brain barrier.